Accessibility
Animation
Accessibility

Poster

The use of low-coverage sequencing of cell-free DNA for monitoringresponse to immune checkpoint inhibitors throughout treatment

November 1, 2018

Published in: SITC (Society for Immunotherapy of Cancer)